Clinical significance of measurement of serum β_2-microglobulin in patients with multiple myeloma
Mei Xu-qia
Abstract
Mei Xu-qia
Abstract
Objective To explore the clinical significance of serum measurement of β2-microglobulin in patients with multiple myeloma(MM).Methods ELISA were used to detect the levels of β2-microglobulin in serum specimens.Results The level of β2-microglobulin in preliminary-diagnosed patients with multiple myeloma was significantly higher than that in healthy controls(P0.05).The level of β2-microglobulin in multiple myeloma patients with better therapeutic effect was significantly lower than that in preliminary-diagnosed patients with multiple myeloma(P0.05).Conclusion β2-microglobulin may be used as an indicator of evaluation of therapeutic effect and prognosis of multiple myeloma.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To explore the clinical significance of serum measurement of β2-microglobulin in patients with multiple myeloma(MM).Methods ELISA were used to detect the levels of β2-microglobulin in serum specimens.Results The level of β2-microglobulin in preliminary-diagnosed patients with multiple myeloma was significantly higher than that in healthy controls(P0.05).The level of β2-microglobulin in multiple myeloma patients with better therapeutic effect was significantly lower than that in preliminary-diagnosed patients with multiple myeloma(P0.05).Conclusion β2-microglobulin may be used as an indicator of evaluation of therapeutic effect and prognosis of multiple myeloma.
Key concepts: Beta-2 microglobulin, Multiple myeloma, Medicine, Clinical significance, Internal medicine, Myeloma protein, Gastroenterology, Oncology